Proxy adviser backs ouster of Progenics CEO in activist battle by Kyle Blankenship Monday, October 28, 2019 An activist investor is angling to oust Progenics' CEO and put three nominees on the drugmaker's board. Backing from a major proxy adviser helps.
Progenics buys a manufacturing facility for radiotherapeutic by Eric Palmer Tuesday, February 12, 2019 Progenics last year picked up an FDA approval for its orphan radiotherapeutic. Now it has picked up a manufacturing facility to produce it in.
